Search Results - "Seppi, Dario"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study by Calabrese, Massimiliano, Rinaldi, Francesca, Seppi, Dario, Favaretto, Alice, Squarcina, Letizia, Mattisi, Irene, Perini, Paola, Bertoldo, Alessandra, Gallo, Paolo

    Published in Radiology (01-12-2011)
    “…To evaluate whether diffusion-tensor imaging can be combined with double inversion recovery to improve the detection of structural changes occurring in the…”
    Get full text
    Journal Article
  2. 2

    Characterization of antiseizure medications effects on the EEG neurodynamic by fractal dimension by Porcaro, Camillo, Seppi, Dario, Pellegrino, Giovanni, Dainese, Filippo, Kassabian, Benedetta, Pellegrino, Luciano, De Nardi, Gianluigi, Grego, Alberto, Corbetta, Maurizio, Ferreri, Florinda

    Published in Frontiers in neuroscience (07-06-2024)
    “…An important challenge in epilepsy is to define biomarkers of response to treatment. Many electroencephalography (EEG) methods and indices have been developed…”
    Get full text
    Journal Article
  3. 3

    Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis by Favaretto, Alice, Lazzarotto, Andrea, Riccardi, Alice, Pravato, Stefano, Margoni, Monica, Causin, Francesco, Anglani, Maria Giulia, Seppi, Dario, Poggiali, Davide, Gallo, Paolo

    Published in PloS one (18-10-2017)
    “…The clinical significance of Virchow Robin spaces (VRS) in inflammatory brain disorders, especially in multiple sclerosis (MS), is still undefined. We analysed…”
    Get full text
    Journal Article
  4. 4

    Disease-Modifying Drugs Reduce Cortical Lesion Accumulation and Atrophy Progression in Relapsing-Remitting Multiple Sclerosis: Results from a 48-Month Extension Study by Seppi, Dario, Favaretto, Alice, Atzori, Matteo, Perini, Paola, Rinaldi, Francesca, Gallo, Paolo

    Published in Multiple Sclerosis International (01-01-2015)
    “…Cortical lesions (CLs) and atrophy are pivotal in multiple sclerosis (MS) pathology. This study determined the effect of disease modifying drugs (DMDs) on CL…”
    Get full text
    Journal Article
  5. 5

    Cortical Pathology in RRMS: Taking a Cue from Four Sisters by Calabrese, Massimiliano, Seppi, Dario, Cocco, Eleonora, Poretto, Valentina, Rinaldi, Francesca, Perini, Paola, Gallo, Paolo

    Published in Multiple Sclerosis International (01-01-2012)
    “…Background. Although grey matter pathology is a relevant aspect of multiple sclerosis (MS) both with physical and cognitive rebounds, its pathogenesis is still…”
    Get full text
    Journal Article
  6. 6

    Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset by Seppi, Dario, Puthenparampil, Marco, Federle, Lisa, Ruggero, Susanna, Toffanin, Elisabetta, Rinaldi, Francesca, Perini, Paola, Gallo, Paolo

    Published in Journal of neuroimmunology (15-05-2014)
    “…Abstract The cerebrospinal fluid levels of interleukin-1 beta and structural magnetic resonance parameters of cortical damage, i.e., cortical lesion number and…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    No evidence of JC-virus reactivation in natalizumab-treated Multiple Sclerosis patients: a 18-month follow-up by Rinaldi, Luciano, Rinaldi, Francesca, Perini, Paola, Calabrese, Massimiliano, Seppi, Dario, Grossi, Paola, Mattisi, Irene, Barzon, Luisa, Mengoli, Carlo, Sanzari, Mariacolomba, Palu', Giorgio, Gallo, Paolo

    “…Background and aim: Natalizumab in multiple sclerosis (MS), has been associated to progressive multifocal leukoencephalopathy (PML), a fatal disease caused by…”
    Get full text
    Journal Article